Tirofiban Superior to Aspirin in Stroke Without Large Occlusion Tirofiban Superior to Aspirin in Stroke Without Large Occlusion

Among patients with disabling strokes without medium or large occlusions, more of those taking tirofiban had good function at 90 days than those on aspirin, results of the RESCUE BT2 trial show.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news